Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 32051 - 32075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	SLC25A20	788	upregulated	Cisplatin results in increased expression of SLC25A20 mRNA	3p21.31	A20427
Cisplatin	Approved Investigational	SLC2A1	6513	upregulated	Cisplatin results in increased expression of SLC2A1 mRNA	1p34.2	A20427
Cisplatin	Approved Investigational	SLC2A11	66035	upregulated	Cisplatin results in increased expression of SLC2A11 mRNA	22q11.23	A20427
Cisplatin	Approved Investigational	SLC30A1	7779	upregulated	Cisplatin results in increased expression of SLC30A1 mRNA	1q32.3	A22204
Cisplatin	Approved Investigational	SLC30A3	7781	upregulated	Cisplatin results in increased expression of SLC30A3 mRNA	2p23.3	A22204
Cisplatin	Approved Investigational	SLC31A1	1317	upregulated	Cisplatin results in increased expression of SLC31A1 mRNA	9q32	A22263 A21773
Cisplatin	Approved Investigational	SLC31A1	1317	upregulated	[Cisplatin results in increased expression of SP1 protein] which results in increased expression of SLC31A1 mRNA	9q32	A21773
Cisplatin	Approved Investigational	SLC31A2	1318	upregulated	Cisplatin results in increased expression of SLC31A2 mRNA	9q32	A22264
Cisplatin	Approved Investigational	SLC35E3	55508	upregulated	Cisplatin results in increased expression of SLC35E3 mRNA	12q15	A22204
Cisplatin	Approved Investigational	SLC35E4	339665	upregulated	Cisplatin results in increased expression of SLC35E4 mRNA	22q12.2	A22204
Cisplatin	Approved Investigational	SLC39A14	23516	upregulated	Cisplatin results in increased expression of SLC39A14 mRNA	8p21.3	A22204
Cisplatin	Approved Investigational	SLC39A4	55630	upregulated	Cisplatin results in increased expression of SLC39A4 mRNA	8q24.3	A22203
Cisplatin	Approved Investigational	SLC3A2	6520	upregulated	Cisplatin results in increased expression of SLC3A2 mRNA	11q12.3	A20427
Cisplatin	Approved Investigational	SLC6A9	6536	downregulated	Cisplatin results in decreased expression of SLC6A9 mRNA	1p34.1	A20427
Cisplatin	Approved Investigational	SLC7A1	6541	upregulated	Cisplatin results in increased expression of SLC7A1 mRNA	13q12.3	A20427
Cisplatin	Approved Investigational	SLC7A11	23657	downregulated	Cisplatin results in decreased expression of SLC7A11 mRNA	4q28.3	A20662
Cisplatin	Approved Investigational	SLC7A5	8140	upregulated	Cisplatin results in increased expression of SLC7A5 mRNA	16q24.2	A20427
Cisplatin	Approved Investigational	SLIT1	6585	downregulated	Cisplatin results in decreased expression of SLIT1 mRNA	10q24.1	A20660
Cisplatin	Approved Investigational	SMAD3	4088	downregulated	Cisplatin results in decreased expression of SMAD3 mRNA	15q22.33	A22204
Cisplatin	Approved Investigational	SMOX	54498	upregulated	Cisplatin results in increased expression of SMOX mRNA	20p13	A22203
Cisplatin	Approved Investigational	SMYD3	64754	downregulated	Cisplatin results in decreased expression of SMYD3 mRNA	1q44	A22204
Cisplatin	Approved Investigational	SNAI1	6615	upregulated	Cisplatin results in increased expression of SNAI1 mRNA	20q13.13	A22239
Cisplatin	Approved Investigational	SNAI2	6591	upregulated	Cisplatin results in increased expression of SNAI2 mRNA	8q11.21	A22204 A22239
Cisplatin	Approved Investigational	SOCS1	8651	downregulated	Cisplatin results in decreased expression of SOCS1 mRNA	16p13.13	A20666
Cisplatin	Approved Investigational	SOD2	6648	upregulated	Cisplatin results in increased expression of SOD2 mRNA	6q25.3	A22205

Displaying entries 32051 - 32075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability